Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 35, 2009 - Issue 11
Submit an article Journal homepage
82
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423—a new phthalimido-desmuramyl-dipeptide derivative with immunomodulating activity

Polona Smrdel Lek Pharmaceuticals, Ljubljana, Slovenia; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
,
Iztok Grabnar Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
,
Igor Locatelli Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
,
Manica Černe Lek Pharmaceuticals, Ljubljana, Slovenia
,
Samo Andrenšek Lek Pharmaceuticals, Ljubljana, Slovenia
,
Nataša Kovačič Erico Velenje, Institute of Ecological Research, Velenje, Slovenia
,
Albin Kristl Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
,
Marija Bogataj Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
,
Uroš Urleb Lek Pharmaceuticals, Ljubljana, Slovenia; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
&
Aleš Mrhar Faculty of Pharmacy, University of Ljubljana, Ljubljana, SloveniaCorrespondence[email protected]
 show all
Pages 1293-1304 | Received 28 Aug 2008, Accepted 11 Mar 2009, Published online: 16 Oct 2009

References

  • Kuby J. (1994). Immunology. 2nd ed. New York: Freeman H.W. Co, 297–322.
  • Feldmann M, Brennan M. (2001). Cytokines and diseases. In: Oppenheim JJ, Feldmann M, eds. Cytokine reference, vol. 1. London, UK: Academic Press, 35–52.
  • Asadullah K, Sterry W, Volk HD. (2003). Interleukin-10 therapy—review of new approach. Pharmacol Rev, 55:241–69.
  • Moore KW, De Waal Malefyt R, Coffman RL, O'Garra A. (2001). Interleukin-10 and the interleukine-10 receptor. Annu Rev Immunol, 19:683–765.
  • Wakkach A, Cottrez F, Groux H. (2000). Can interleukin-10 be used as a true immunoregulatory cytokine?. Eur Cytokine Netw, 11:153–60.
  • Lindsay JO, Hodgson HJF. (2001). The immunoregulatory cytokine interleukin-10—a therapy for Crohn's disease?. Aliment Pharmacol Ther, 15:1709–16.
  • De Waal Malefyt R. (2001). IL-10. In: Oppenheim JJ, Feldmann M, eds. Cytokine reference, vol. 1. London, UK: Academic Press, 165–86.
  • Ochi C, Norisada N, Moriguchi M, Stalc A, Urleb U, Muraoka S. (1999). Interleukin-10 inducing activity of LK423, a phthalimido-desmuramyldipepdide compound. Arzneimittel-Forschung/Drug Res, 49:71–9.
  • Yoneda F, Muraoka S, Moriguchi M, Norisada N, Ochi C, Stalc A, (2001). Anti-inflammatory medicinal compositions. Patent WO 0135982 A1.
  • Moriguchi M, Urabe K, Norisada N, Ochi C, Stalc A, Urleb U, . (1999). Therapeutic effect of LK 423, a phthalimido-desmuramyl-dipeptide compound, on dextran sulfate sodium—induced colitis in rodents through restoring their interleukin-10 producing capacity. Arzneimittel-Forschung/Drug Res, 49:184–92.
  • Urleb U, Krbavčič A, Sollner M, Kikelj D, Pečar S. (1995). Synthesis of phthalimido-desmuramylpeptide analogues as potential immunomodulating agents. Arch Pharm, 328:113–7.
  • Albert A, Serjeant EP. (1984). The determination of ionization constants: A laboratory manual. 3rd ed. New York: Chapman and Hall, 56–60.
  • Bogataj M, Mrhar A, Lavri1 A, Černe M, Tibaud D, Štalc A, . (2005). Gastroresistant pharmaceutical dosage form comprising N-(2-(2-phthalimidoethoxy-)acetyl)-L-alanyl-D-glutamic acid (LK-423). Patent WO 2005/092295 A1.
  • Smrdel P, Bogataj M, Zega A, Planinšek O, Mrhar A. (2008). Shape optimization and characterization of polysaccharide beads prepared by ionotropic gelation. J Microencapsul, 25:90–105.
  • Legen I, Kristl A. (2003). pH and energy dependent transport of ketoprofen across rat jejunum in vitro. Eur J Pharm Biopharm, 56:87–94.
  • Van Dongen JJ, Remie R, Rensema JW, Van Wunnik GHJ. (1998). Manual of microsurgery on the laboratory rat. Part I. Amsterdam, The Netherlands: Elsevier science B.V.
  • Tuleu C, Andrieux C, Boy P, Chaumeil JC. (1999). Gastrointestinal transit of pellets: Effect of size and density. Int J Pharm, 180:123–31.
  • De Zwart LL, Rompelberg CJM, Sips AJAM, Welink J, Van Engelen JGM. (1999). Anatomical and physiological differences between various species used in studies on the pharmacokinetics and toxicology of xenobiotics. RIVM report 623860010. Bilthoven, The Netherlands: RIVM.
  • Kararli TT. (1995). Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos, 16:351–80.
  • Rubio-Aliga I, Hannelore D. (2002). Mammalians peptide transporters as targets for drug delivery. Trends Pharmacol Sci, 23:434–40.
  • Walter E, Kissel T, Amidon LG. (1996). The intestinal peptide carrier: A potential transport system for small peptide derived drugs. Adv Drug Deliv Rev, 20:33–58.
  • Norinder U, Haeberlein M. (2003). Calculated molecular properties and multivariate statistical analysis in absorption prediction. In: Van de Waterbeemd FH, Lennernäs H, Artursson P, eds. Drug bioavailability: Estimation of solubility, permeability, absorption and bioavailability, vol. 18. Weinheim, Germany: Wiley-VCH Verlag, 358–405.
  • Rinaki E, Valsami G, Macheras P. (2003). Quantitative biopharmaceutics classification system: The central role of dose/solubility ratio. Pharm Res, 20:1917–25.
  • He YL, Murby S, Warhurst G, Gifford L, Walker D, Ayrton J, . (1998). Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and D-peptides. J Pharm Sci, 87:626–33.
  • Herfarth H, Schölmerich J. (2002). IL-10 therapy in Crohn's disease: At the crossroads. Gut, 50:146–7.
  • Steidler L, Hans W, Schotte L, Neirynck S, Obermeir F, Falk W, . (2000). Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science, 289:1352–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.